The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Evans John M. since 2020.
This trader's CIK number is 1786304.
At the time of last reporting, Evans John M. was the CEO of Beam Therapeutics Inc.. (stock ticker symbol BEAM).
Also see all insider trading activities at Beam Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | BEAM | 0 | $0 | 30,663 | $562,696 | 0 | $0 |
| 2024 | BEAM | 0 | $0 | 258,102 | $7,079,017 | 0 | $0 |
| 2023 | BEAM | 0 | $0 | 11,654 | $345,336 | 13,850 | $99,997 |
| 2022 | BEAM | 0 | $0 | 156,261 | $7,955,487 | 59,450 | $245,231 |
| 2021 | BEAM | 0 | $0 | 140,000 | $12,300,793 | 70,700 | $72,821 |
| 2020 | BEAM | 0 | $0 | 0 | $0 | 115,000 | $118,450 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-04-01 | BEAM | Sale | 30,663 | 18.35 | 562,696 |
| 2024-09-30 | BEAM | Sale | 60,000 | 24.60 | 1,476,000 |
| 2024-06-27 | BEAM | Sale | 60,000 | 24.50 | 1,470,180 |
| 2024-04-01 | BEAM | Sale | 18,102 | 32.13 | 581,617 |
| 2024-03-28 | BEAM | Sale | 60,000 | 33.86 | 2,031,420 |
| 2024-01-31 | BEAM | Sale | 60,000 | 25.33 | 1,519,800 |
| 2023-04-04 | BEAM | Sale | 6,493 | 29.09 | 188,907 |
| 2023-04-03 | BEAM | Sale | 5,161 | 30.31 | 156,429 |
| 2023-03-31 | BEAM | Option Ex | 13,850 | 7.22 | 99,997 |
| 2022-10-31 | BEAM | Sale | 50,000 | 46.48 | 2,323,950 |
| 2022-07-28 | BEAM | Sale | 50,000 | 66.55 | 3,327,500 |
| 2022-04-28 | BEAM | Option Ex | 59,450 | 4.12 | 245,231 |
| 2022-04-28 | BEAM | Sale | 50,000 | 38.68 | 1,933,950 |
| 2022-03-31 | BEAM | Sale | 6,261 | 59.11 | 370,087 |
| 2021-10-06 | BEAM | Option Ex | 27,700 | 1.03 | 28,531 |
| 2021-10-06 | BEAM | Sale | 47,700 | 83.97 | 4,005,130 |
| 2021-08-19 | BEAM | Sale | 20,000 | 98.92 | 1,978,340 |
| 2021-08-19 | BEAM | Option Ex | 12,000 | 1.03 | 12,360 |
| 2021-07-07 | BEAM | Sale | 25,000 | 106.46 | 2,661,550 |
| 2021-07-07 | BEAM | Option Ex | 25,000 | 1.03 | 25,750 |
| 2021-04-21 | BEAM | Sale | 25,000 | 70.06 | 1,751,599 |
| 2021-04-23 | BEAM | Option Ex | 6,000 | 1.03 | 6,180 |
| 2020-12-30 | BEAM | Sale | 22,300 | 85.39 | 1,904,174 |
| 2020-04-16 | BEAM | Option Ex | 115,000 | 1.03 | 118,450 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Evans John M. (CEO of Beam Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.